Laden...
| No images? Click here Friday 10.29.21 | Issue 131 Subscribe to receive this weekly update© WHO Coronavirus disease (COVID-19) updates A virtual press briefing with simultaneous translation in all UN languages with the participation of the WHO Director-General is planned for next week. Media advisories with Zoom links/dial-in details will be emailed in advance. For the latest news from WHO on COVID-19 and other breaking health stories, read WHO's news updates. 30-31October WHO Director-General takes part in G20 Summit Dr Tedros Adhanom Ghebreyesus, WHO Director-General, will speak at the G20 Summit in Rome, Italy, on 30-31 October. Key issues on the Summit agenda include the COVID-19 pandemic response, climate change and addressing inequality. See open letter on meeting the COVID-19 vaccine commitments and an appeal to G20 leaders to make vaccines accessible to people on the move. 31 October On World Cities Day 2021, WHO will call on countries to build resilient and healthy cities. Well over half the world’s population already lives in towns and cities. By 2050, that proportion is expected to increase to almost 70%. More will be available at this link (live at 10:00 CET Sunday). 31 October-12 November UN Climate Change Conference (COP26) The global health community is driving transformational change to protect the health of people and the planet. WHO and its partners are hosting an extensive series of events at the COP26 UN climate conference, in order to ensure health and equity are placed at the center of the climate negotiations. Key events include the 2021 Global Conference on Health and Climate Change on November 6, which will convene health leaders from around the world on the sideline of COP26, and the announcement of country commitments under the COP26 Health Programme on November 9. An overview of all health and climate events can be consulted here. Check out these resources on the COP26 Health Programme. Wednesday, 3 November New research on the global burden of Group B streptococcus for infant health and survival New research from WHO and the London School of Hygiene & Tropical Medicine (LSHTM) reveals the alarming global impact of Group B streptococcus (GBS) in pregnancy – detailing the associated burden of preterm births, neurological disabilities, still term births and infant deaths. The report calls urgently for the development of maternal vaccines against GBS to reduce this toll, emphasizing they could be extremely cost-effective – with significant health benefits – in all regions of the world. The report will be launched at the global conference on GBS, the ISSAD conference, being held by WHO and LSHTM from Wednesday, 3 November, to Friday, 5 November. This conference aims to mobilise researchers on how to close data gaps and accelerate science to reduce the impacts of this life threatening bacterium worldwide. Materials available on request next week. EMBARGOED UNTIL 00:30 CET on Wednesday 3 November 2021. Friday, 5 November Accelerating access to genomic technologies Advances in science and technology hold great promise for new and improved ways to address global health and to support healthier populations worldwide. The WHO Science Council has identified genomic technologies as having significant implications for public health, given their broad applications across health and disease states and throughout the human lifespan, as abundantly documented in wealthy countries and during the Covid-19 pandemic. The Science Council is organizing a series of three workshops to better understand ways to accelerate access to genomics technologies, especially in low- and middle-income countries. Objectives of the workshops: · To gather information about the benefits and use of genomic technologies for low- and middle-income countries · To discuss the impediments to implementation, and brainstorm on possible solutions · To gain perspective on approaches and lessons learned from both successful and failed implementations · To engage communities of experts and stakeholders in developing recommendations based on understanding diverse needs, applications, and considerations of low- and middle-income countries To find out more and register, see: WHO Science Council Workshop Series: Accelerating access to genomic technologies for global health. Latest Global Health Matters podcast on Sign up for our newsletters here. Check out the WHO series, Science in 5. WHO Media contacts: You are receiving this NO-REPLY email because you are included on a WHO mail list.
|
Laden...
Laden...
